Physician profile
Daniel G Miles
NPI 1124414412
$14,438.44
in general payments reported to CMS, 2019-2025
28 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,302 · 2021: $1,513 · 2022: $3,089 · 2023: $2,483 · 2024: $2,312 · 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,535.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,534.68 | 2021-2025 | Hawkone, Endurant Iis, Turbohawk |
| Medtronic Vascular, INC. | $3,301.63 | 2020 | |
| Silk Road Medical, INC. | $2,059.37 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $923.98 | 2022-2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $713.18 | 2022-2024 | Zilver Ptx |
| Penumbra, INC. | $598.17 | 2021-2025 | Indigo System, Penumbra System |
| Endologix LLC | $492.80 | 2023-2024 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Bolton Medical INC | $454.59 | 2022-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Boston Scientific Corporation | $423.42 | 2022-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Inari Medical, INC. | $421.39 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $333.81 | 2024-2025 | Alphavac |
| Lemaitre Vascular, INC. | $271.85 | 2023-2025 | Restoreflow, Artegraft Vascular Graft, Xenosure Biologic Patch |
| Shockwave Medical, INC | $183.45 | 2024-2025 | Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $178.56 | 2022 | |
| Stryker Corporation | $75.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $65.76 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Kerecis Limited | $62.86 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Teleflex LLC | $48.59 | 2023-2024 | Manta |
| Edwards Lifesciences Corporation | $41.93 | 2025 | Mitris Resilia Mitral Valve |
| Cagent Vascular INC | $41.16 | 2025 | Serrantor |
| Solventum Corporation | $38.18 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Tactile Systems Technology INC | $37.51 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Argon Medical Devices, INC. | $33.67 | 2025 | Clot Management |
| Smith+Nephew, INC. | $23.55 | 2023 | Pico 7 |
| Acera Surgical, INC. | $21.36 | 2025 | Restrata Wound Matrix |
| Mozarc Medical US LLC | $20.55 | 2024 | Palindrome |
| Amgen INC. | $18.98 | 2024 | Repatha |
| Molnlycke Health Care US, LLC | $17.62 | 2024 | Avance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.